XOMA Announces Stock Repurchase Program of up to $50 Million
EMERYVILLE, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board […]
Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024
GAITHERSBURG, Md., Jan. 02, 2024 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced an abstract […]
Apogee Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO and WALTHAM, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company […]
AppTech Successfully Boards its First International Airport Onto its Newly Acquired FinZeo Platform for Payment Processing
CARLSBAD, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — AppTech Payments Corp. (Nasdaq: APCX) (“AppTech” or the “Company”), a pioneering Fintech company […]
TSX News -
Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA
Trogarzo®IM maintenance dosing aims to further enhance the convenience of non-oral therapy for heavily treatment-experienced adults with HIV Submission comes […]
Doré Copper Announces Closing Of Rights Offering
Not for distribution to United States news wire services or for dissemination in the United States TORONTO, Jan. 02, 2024 […]
Watsco Declares $2.45 Quarterly Dividend and Commemorates Paying Dividends for 50 Consecutive Years
MIAMI, Jan. 02, 2024 (GLOBE NEWSWIRE) — Watsco, Inc.’s (NYSE: WSO) Board of Directors has declared a regular quarterly cash […]
Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID
ATLANTA, Jan. 02, 2024 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on developing […]
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
DURHAM, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced […]
ASLAN Pharmaceuticals Announces Participation in January Investor Conferences
SAN MATEO, Calif. and SINGAPORE, Jan. 02, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company […]
